Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy

DSpace Repository

Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy

Author: Zoja, Carlamaria; Locatelli, Monica; Corna, Daniela; Villa, Sebastian; Rottoli, Daniela; Nava, Valeria; Verde, Roberta; Piscitelli, Fabiana; Di Marzo, Vincenzo; Fingerle, Juergen; Adam, Jean-Michel; Rothenhaeusler, Benno; Ottaviani, Giorgio; Benardeau, Agnes; Abbate, Mauro; Rernuzzi, Giuseppe; Benigni, Ariela
Tübinger Autor(en):
Fingerle, Jürgen
Published in: Nephron (2016), Bd. 132, H. 1, S. 59-69
Verlagsangabe: Karger
Language: English
Full text: http://dx.doi.org/10.1159/000442679
ISSN: 2235-3186
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)